Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 16 12:10PM ET
3.14
Dollar change
+0.20
Percentage change
6.80
%
Index- P/E- EPS (ttm)-35.71 Insider Own0.25% Shs Outstand0.75M Perf Week-17.80%
Market Cap2.36M Forward P/E- EPS next Y-18.41 Insider Trans0.00% Shs Float0.75M Perf Month-31.74%
Income-16.08M PEG- EPS next Q-4.54 Inst Own84.35% Short Float8.99% Perf Quarter-65.87%
Sales0.00M P/S- EPS this Y44.37% Inst Trans- Short Ratio2.46 Perf Half Y-79.07%
Book/sh0.71 P/B4.40 EPS next Y1.60% ROA-167.56% Short Interest0.07M Perf Year-88.70%
Cash/sh1.40 P/C2.24 EPS next 5Y- ROE-220.02% 52W Range2.94 - 44.80 Perf YTD-66.09%
Dividend Est.- P/FCF- EPS past 5Y34.89% ROI-3564.97% 52W High-92.99% Beta0.44
Dividend TTM- Quick Ratio1.60 Sales past 5Y0.00% Gross Margin- 52W Low6.80% ATR (14)0.58
Dividend Ex-Date- Current Ratio1.60 EPS Y/Y TTM7.82% Oper. Margin0.00% RSI (14)29.27 Volatility11.85% 14.07%
Employees10 Debt/Eq0.25 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price40.00
Option/ShortNo / Yes LT Debt/Eq0.02 EPS Q/Q50.75% Payout- Rel Volume0.79 Prev Close2.94
Sales Surprise- EPS Surprise36.48% Sales Q/Q- EarningsMar 08 BMO Avg Volume27.41K Price3.14
SMA20-21.82% SMA50-46.93% SMA200-70.25% Trades Volume9,894 Change6.80%
Date Action Analyst Rating Change Price Target Change
Mar-11-21Initiated ROTH Capital Buy $13
Nov-13-17Reiterated H.C. Wainwright Buy $4.50 → $1.50
Aug-10-16Reiterated Maxim Group Buy $5 → $2
Apr-18-16Initiated Rodman & Renshaw Buy $5
Jun-02-14Resumed Maxim Group Buy $5
May-09-14Initiated Maxim Group Buy $5
Apr-15-24 07:00AM
Apr-02-24 07:00AM
Mar-27-24 04:43PM
Mar-10-24 08:17AM
Mar-08-24 10:45PM
07:00AM Loading…
07:00AM
Mar-01-24 07:00AM
Feb-21-24 07:00AM
Jan-10-24 07:00AM
Dec-14-23 07:00AM
Nov-20-23 12:54PM
Nov-15-23 07:12AM
07:00AM
Nov-08-23 07:00AM
Oct-24-23 07:00AM
04:01PM Loading…
Sep-08-23 04:01PM
Aug-30-23 05:11PM
Aug-15-23 10:04PM
07:06AM
07:00AM
Aug-08-23 07:00AM
Aug-03-23 08:22AM
Aug-01-23 07:00AM
Jul-17-23 07:00AM
Jun-02-23 04:49PM
May-18-23 12:41PM
May-12-23 09:13PM
07:06AM
07:00AM
May-05-23 07:00AM
05:25PM Loading…
Apr-10-23 05:25PM
Apr-04-23 01:19PM
Apr-03-23 08:37AM
Mar-31-23 07:00AM
Mar-24-23 04:01PM
Mar-16-23 07:00AM
Dec-28-22 09:59AM
Dec-07-22 07:00AM
Nov-15-22 07:00AM
Nov-08-22 07:00AM
Nov-07-22 07:00AM
Oct-24-22 07:00AM
Oct-23-22 09:36AM
Sep-30-22 11:24AM
Sep-06-22 07:00AM
Aug-16-22 07:00AM
Aug-09-22 07:00AM
Jun-13-22 12:10PM
May-17-22 07:00AM
May-16-22 07:51AM
May-10-22 07:00AM
Apr-13-22 04:30PM
Apr-12-22 04:01PM
Apr-06-22 07:00AM
Mar-11-22 07:00AM
Mar-08-22 04:30PM
Mar-04-22 07:00AM
Jan-05-22 07:00AM
Dec-13-21 07:00AM
Dec-06-21 04:22AM
Nov-12-21 07:00AM
Nov-05-21 08:00AM
Nov-04-21 09:01AM
Oct-27-21 07:00AM
Sep-20-21 04:30PM
Aug-25-21 10:24AM
Aug-24-21 11:00AM
08:33AM
07:00AM
Aug-13-21 07:00AM
Aug-06-21 07:00AM
Jun-22-21 07:00AM
Jun-15-21 03:22PM
Jun-09-21 01:56AM
May-27-21 08:00AM
May-14-21 07:00AM
06:45AM
May-07-21 07:00AM
Apr-26-21 09:00AM
Apr-22-21 07:00AM
Apr-12-21 07:00AM
Apr-05-21 08:03AM
07:00AM
Mar-11-21 07:00AM
Mar-10-21 07:00AM
05:30AM
Mar-03-21 04:01PM
Feb-18-21 04:01PM
Feb-16-21 07:15AM
Feb-13-21 07:00AM
Feb-10-21 07:08AM
07:00AM
Dec-21-20 02:05PM
Dec-11-20 03:48AM
Nov-19-20 07:00AM
Nov-13-20 07:00AM
Nov-06-20 08:00AM
Oct-22-20 07:00AM
Sep-18-20 12:00PM
Sep-09-20 08:00AM
Bio-Path Holdings, Inc. is a biotechnology company, which engages in the development of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline includes Prexigebersen, BP1001-A, BP1002, and BP1003. The company was founded by Peter H. Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.